Multi-Omic Endotyping of Chronic Pain: Leveraging Proteomic & Metabolomic Signatures for Biomarker Discovery & Patient Stratification
11:30 am - Wednesday 27th January 2027
- Defining biologically distinct pain endotypes through integrated proteomic and metabolomic profiling
- Identifying molecular pathways associated with pain severity, progression, and treatment response
- Developing translatable biomarkers to improve patient selection and clinical trial design
- Utilizing human multi-omic datasets to inform target identification and therapeutic development
